• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Thyroid Cancer - Articles and news items

cdf

Eisai calls for immediate solution to CDF black hole

Industry news / 8 July 2016 / Victoria White, Digital Content Producer

Eisai has expressed concern that patients in England and Wales will have to wait three years to access Lenvatinib due to a ‘black hole’ in the CDF process…

selumetinib

Selumetinib granted Orphan Drug Designation in the US for DTC

Industry news / 12 May 2016 / Victoria White, Digital Content Producer

The FDA has granted Orphan Drug Designation for selumetinib for adjuvant treatment of patients with stage III or IV differentiated thyroid cancer (DTC)…

thyroid cancer

Phase II trial of sulfatinib in thyroid cancer starts

Industry news / 2 March 2016 / Victoria White, Digital Content Producer

The trial will evaluate sulfatinib in locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer or medullary thyroid cancer….

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +